Diabetics, you know the score: The more pills you take... the sicker you get.

Well, now Merck wants to "help." They're cutting back on the number of pills -- but don't get too excited: They're not actually reducing the number of drugs.

The company has taken two very risky meds -- the diabetes drug Januvia and the cholesterol-lowering statin Zocor -- and smashed them together to form a newly approved Frankendrug called Juvisync.

That's all the risks of two meds... conveniently delivered in one handy pill.

By itself, Januvia has been linked to almost triple the risk of pancreatic cancer -- the deadly condition that recently killed Steve Jobs.

Zocor, on the other hand, has been linked to myopathy, which can cause your muscles to melt into your bloodstream -- and when those melted muscles reach your kidneys, the organs can shut down completely. (Read more here.)

That's a high price to pay for lower cholesterol -- especially since docs are barking up the wrong tree with this cholesterol business in the first place.

As I've told you before, the real problem isn't high cholesterol -- it's LOW cholesterol, even for diabetics. If you're below 300, you're in the danger zone -- and you need to raise your levels fast, before it's too late.

That might sound loco if everything you know about cholesterol comes from statin commercials -- if you want to learn more click here.

But forget choosing one risky med over another. On their own or in combo pills, they could all bring you down the same path: a lifetime of diabetes.

There actually is one pill that's as close to a diabetes cure as you'll ever find -- and believe it or not, it was actually developed by the drug industry decades ago.

It's called benfotiamine, a synthetic form of thiamine that's fat-soluble so your body can absorb it five times more efficiently. The result: a diabetes repair kit that can undo years or even decades of disease damage.

Don't believe me?

Read this -- and learn the explosive truth that Big Pharma hopes you'll never see.